TransMedics Group, Inc. Made Headway
TransMedics Group, Inc. (TMDX:NASDAQ) jumped higher at $16.36, representing a gain of 30%. On Wed, Feb 23, 2022, TMDX:NASDAQ hit a New 2-Week Low of $12.58. The stock got featured on our News Catalysts scanner on Wed, Feb 23, 2022 at 07:04 PM in the 'EARNINGS' category. From Thu, Feb 10, 2022, the stock recorded 25.00% Up Days and 44.44% Green Days
About TransMedics Group, Inc. (TMDX:NASDAQ)
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the OCS to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.
Top 10 Gainers:
- CYREN Ltd. (CYRN:NASDAQ), 118.89%
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 53.39%
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 41.43%
- South Jersey Industries, Inc. (SJI:NYSE), 39.86%
- Lantheus Holdings, Inc. (LNTH:NASDAQ), 39.12%
- Imperial Petroleum Inc. (IMPP:NASDAQ), 38.94%
- U.S. Well Services, Inc. (USWS:NASDAQ), 37.2%
- The Oncology Institute Inc. (TOI:NASDAQ), 31.23%
- South Jersey Industries Inc. Corporate Units (SJIV:NYSE), 30.59%
- TransMedics Group, Inc. (TMDX:NASDAQ), 30.05%